Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

Advancing Therapeutic Outlook for Autosomal Dom...

Key Highlights The US approval of Jynarque added the much-needed push to the ADPKD treatment market.In the coming years, Bardoxolone methyl is expected to be an effective therapy for ADPKD treatmen...

Jul 29, 2022

Neurostimulation Devices for Chronic Pain
How are Neurostimulation Devices Playing a Vital Role in the Treatment of Chronic Pain?

Around 50 million people in the United States live with—and suffer from—chronic pain. The prevalence of chronic pain has grown significantly over the past few decades due to lifestyle changes, traumatic injury, a rise in critical surgeries, and growth in the overweight or obese population, among serval other underl...

Find More
Latest Pharma News for VistaGen and Merck
VistaGen’s PH94B for Anxiety Disorder; Keytruda for Head and Neck Cancer Treatment; Bavarian Nordic’s Smallpox Vaccine Imvanex; CAMP4 Raises USD 100 Million; Incyte’s WU-CART-007; Incyte’s Opzelura for Vitiligo; AstraZeneca and Merck’s Lynparza; Sumitomo Pharma’s DSP-0390 for Brain Cancer

FDA Approves Incyte’s Opzelura as First Vitiligo Therapy The US Food and Drug Administration has approved Incyte’s Opzelura cream 1.5% for the topical treatment of non-segmental vitiligo in adult and paediatric patients 12 years of age and older. With this approval, Opzelura is the first and only FDA-approved...

Find More
Bronchopulmonary Dysplasia Treatment Market
Exploring Potential New Avenues for Bronchopulmonary Dysplasia Treatment

Bronchopulmonary Dysplasia is the most common long-term respiratory morbidity of low-weight or premature infants, with the risk of development proportional to the degree of prematurity. It is also referred to as chronic lung disease of premature babies. It is a chronic respiratory disease that often occurs in low-w...

Find More

More Views & Analysis

retinal-vein-occlusion-market-assessment
A Market Space Beyond Lucentis and Eylea for Retinal Vein Occlusion Treatment

Competitive inroads by Regeneron’s Eylea in the retinal vein occlusion treatment landscape changed the market once dominated by Roche.Moving forward, RVO’s robust pipeline, along with several VEGF inhibitors, creates trouble for the big ones; Lucentis and Eylea. Retinal vein occlusion is the second most common s...

Find More

Nanobots in Healthcare Sector
How are Nanobots Proving Their Excellence in the Healthcare Industry?

It is estimated that around five billion people are on the verge of losing access to essential healthcare services by 2030, for example, mandatory healthcare services, necessary medicine, and visiting healthcare providers. This issue can further become complex if there is an increase in the shortage of trained heal...

Find More

Wilson's Disease Image
Wilson’s Disease Presents Unique Challenges and Demand for Novel Treatment Therapies

Wilson’s disease is a rare genetic disorder caused by mutations in the P-type ATPase gene. Wilson’s disease causes defective biliary excretion of copper, leading to its accumulation, particularly in the liver and brain. The ATP7B gene is responsible for the transportation of copper from the liver to the intestine t...

Find More

denovoskin-personalized-skin-graft
Can denovoSkin Be A Lifesaver for Burn Victims?

Burn is a global public health problem, causing more than 180,000 deaths per year across the world. The vast majority of these occur in low- and middle-income nations. Moreover, non-fatal burns are a primary source of morbidity, resulting in lengthy hospitalization, deformity, and disability, as well as stigma and ...

Find More

Seizures Alert Devices Preventing Epilepsy
Role of Seizures Alert and Monitoring Devices in the Management of Epilepsy

As per the WHO, roughly 50 million people worldwide have Epilepsy. The burden of Epilepsy is growing in almost every geographic region. According to the Global Burden of Disease report on the burden of neurological diseases, it is observed that idiopathic epilepsy accounted for 5% of all neurological DALYs and 1.3%...

Find More

Genital Warts
VP-102: A Potential Emerging Drug for Genital Warts

Warts are small, benign fleshy growths of the skin or mucous membranes caused by various strains of the human papillomavirus (HPV). Genital Warts (condyloma acuminatum) are the clinical manifestations of a sexually transmitted infection caused by HPV. HPV is the most common sexually transmitted infection ...

Find More

The EU market contains more than 55 biosimilars for around 15 oncology, autoimmune, diabetes, and fe.....

Find More

BK Virus Infection , a member of the polyomavirus family, is typically associated with patients who .....

Find More

Fragile X Syndrome is a syndrome, which results in intellectual disabilities as well as affects the .....

Find More

Advances in continuous glucose monitoring (CGM) has led to a paradigm shift in the management of typ.....

Find More

Asthma is a chronic disease of the air passages characterized by inflammation and narrowing of the a.....

Find More

Cell therapies now are often recommended to treat cancer in several ways, out of which CAR T-cell th.....

Find More